Peter Kabos

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 28, 2026
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases.

|Jan 07, 2025
Metabolic Switch in Endocrine Resistant Estrogen Receptor Positive Breast Cancer.

Heather M Brechbuhl, Amy Han, Kiran Vinod Paul

|Aug 30, 2024
Sticky Business: Progesterone Receptors Mediate Cancer Associated Fibroblast and Breast Cancer Cell Interaction.

Heather M Brechbuhl, Carol A Sartorius

|Dec 02, 2021
Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor-positive breast cancer.

Heather M Brechbuhl, Mengyu Xie, Etana G Kopin

|Aug 22, 2020
Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells.

Heather M Brechbuhl, Kiran Vinod-Paul, Austin E Gillen

Pageof 1

Frequent Collaborators

3 joint publications

Peter Kabos

2 joint publications

Carol A Sartorius

1 joint publications

Aik-Choon Tan

1 joint publications

Srinivas Ramachandran